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Conference Proceedings: Aurora Scientific Day 2019
Select abstracts published herein were presented at the 45th annual Aurora Scientific Day research symposium,
held May 22, 2019, in Milwaukee, Wisconsin. This symposium provides a forum for research projects conducted
by faculty, fellows, residents, and other allied health professionals affiliated with Aurora Health Care, which is
part of Advocate Aurora Health, an integrated health system with hospitals and clinics in Wisconsin and Illinois.

ORAL PRESENTATIONS

The OMMAT Study: Oncological Multisite Massage and
Acupuncture Therapy to Combat the Side Effects of
Routine Care
John R. Burns, Ana C. Perez Moreno, Jessica J. F. Kram,
Jennifer T. Fink, John Scott Maul, Nancy Conway
Department of Integrative Medicine, Aurora Health Care;
Aurora Research Institute; Aurora UW Medical Group;
Center for Urban Population Health; University of WisconsinMilwaukee; Department of Oncology, Aurora Health Care
Background: Patients undergoing treatment for cancer face
side effects (ie, pain, stress, neuropathy, and nausea) related to
diagnosis, treatment, and distress of a life-threatening illness.
Side effects are common, continue throughout treatment, can be
serious, and impact quality of life and survival. Acupuncture and
massage therapy have been shown to improve these side effects.
Purpose: Explore whether massage and acupuncture therapy
could reduce cancer treatment side effects across multiple sites.
Methods: Evidence-based clinical competencies were developed
and applied to ensure quality of therapies provided across
multiple Aurora Cancer Care clinics. Interventions were created
for explicit types of cancer, patient conditions, and complaints.
Pre/postintervention pain, stress, nausea, and neuropathy scores
were recorded (scale: 0 [least] to 10 [worst]). Pre/postintervention
scores were compared using paired t-tests.
Results: A total of 4367 acupuncture treatments (AT) and 4197
massage therapy (MT) treatments were provided to oncology
patients in 2018. Comparing symptoms before and after AT
revealed mean scores for pain (2.99 pre vs 1.42 post), neuropathy
(2.75 vs 1.66), stress (3.02 vs 1.18), and nausea (0.45 vs 0.31)
all were significantly different ( P<0.001). F or t he m ajority of
AT there was a reported decrease in pain, stress, and neuropathy
(61.7%, 68.8%, and 47.9%, respectively). Analysis of pre-MT
and post-MT symptom severity revealed mean scores for pain
(1.61 pre vs 0.84 post), neuropathy (1.17 vs 0.77), nausea (0.26
vs 0.16), and stress (1.94 vs 0.93) all were significantly different
(P<0.001). The impact of MT was greater on reducing stress
(42.5%) and pain (34.4%).
Conclusion: Both therapies were effective at reducing symptom
severity. AT was effective at decreasing both pain and stress,
closely followed by neuropathy. MT impacted stress more
than any of the other symptoms. Our findings s upport a larger
randomized controlled trial to further assess the impact of
massage and acupuncture therapy to combat the side effects
associated with routine care across multiple cancer clinics.
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Requirement for Electrical Cardioversion After Dofetilide
Loading in Patients With Persistent Atrial Fibrillation Is
Associated With Increased Recurrence
Bilal M. Omery, Khawaja Afzal Ammar, Arshad Jahangir, Andy
Kieu, Tarek Ajam, Akshar Jaglan, Jasbir Sra, Atul Bhatia
Aurora Cardiovascular Services; Department of Internal
Medicine, Aurora Health Care
Background: Atrial fibrillation (AF) recurrence after
cardioversion following dofetilide loading with or without
electrical cardioversion (EC) is reportedly 36% to 53%. Although
factors associated with AF recurrence are not well defined, it
has been suggested that cardioversion during dofetilide loading
without EC is associated with less AF recurrence.
Purpose: Investigate factors associated with AF recurrence
within 1 year after cardioversion from persistent atrial fibrillation
to sinus rhythm during dofetilide loading with or without EC.
Methods: We identified patients with persistent AF who had
dofetilide loading from January 2014 to October 2017 and divided
them into those who pharmacologically converted to sinus
rhythm or required EC. Patients were longitudinally followed for
1 year for AF recurrence, stroke, torsades de pointes (TDP), and
mortality.
Results: Out of 132 patients (mean age: 64.7 ± 10.2 years; 67%
male; 20% with left ventricular ejection fraction [LVEF] of 35%
or less; 80% with CHA2DS2-VASc score of at least 2), 65 patients
(49%) required EC. AF recurrence within 1 year occurred in
59 patients (45%). One patient (0.75%) experienced torsades
de pointes the night after EC and subsequently died (mortality:
0.75%) with heart failure. AF recurrence was more prevalent
among patients who underwent EC (odds ratio [OR]: 2.09, 95%
CI: 1.04–4.20; P=0.04). AF recurrence in those who underwent
EC continued to be higher in multivariate analyses, even after
adjustment for CHA2DS2-VASc score, LVEF of 35% or less, and
left atrial volume index greater than 48 mL/m2. Stratum-specific
odds ratios revealed this association progressively decreased in
those with sleep apnea (OR: 6.5; P=0.01), total daily dofetilide
dose of 1000 micrograms (OR: 3.84, P=0.01), left atrial volume
index greater than 34 mL/m2 (OR: 3.15; P=0.01), CHA2DS2VASc score of at least 2 (OR: 2.65; P=0.01), LVEF greater than
35% (OR: 2.41; P=0.03), male sex (OR: 2.48; P=0.04), and no
prior AF ablation (OR: 2.37; P=0.02).
Conclusion: The need for EC after dofetilide loading was
associated with increased AF recurrence incidence within 1 year
despite adjustment for advanced substrate. The stronger association
in certain clinical subsets warrants further investigation.

Supplement

Can Magnetic Resonance Imaging Predict Pathologic
Findings in Endometrioid Endometrial Cancer Patients?

Epidemiologic Survey of Legionella Antigen Tests at
Aurora Health Care

Elizabeth Dickson Michelson, Jessica J. F. Kram, Kayla
Heslin, David Baugh, Vikram Bamra, Salik Nazeer, Jia Hao
Hu, Abhishek Shukla, Scott A. Kamelle

Caroline P. Toberna, Hannah M. William, Dennis J.
Baumgardner, Jessica J. F. Kram, Kayla Heslin

Department of Gynecologic Oncology, Aurora West Allis
Medical Center; Aurora UW Medical Group; Center for
Urban Population; Aurora Research Institute; Departments
of Radiology, Pathology, and Gynecologic Oncology, Aurora
St. Luke's Medical Center
Background: Endometrial cancer is the most common
gynecologic cancer in the United States. Currently, hysterectomy
and lymphadenectomy (more recently with sentinel lymph node
removal only) are recommended for endometrioid endometrial
cancer (EEC) patients at greater than low risk of cancer spread,
with hysterectomy only recommended for patients at low
risk. Our previously published risk schema, as well as risk
schemas from other institutions, used tumor diameter (TD) and
myometrial invasion (MI) to predict low-risk patients. Use of
magnetic resonance imaging (MRI) may allow for TD and MI
measurement preoperatively.
Purpose: Our study aimed to assess the feasibility of accurately
measuring TD and MI in patients with endometrioid endometrial
cancer using preoperative contrast-enhanced MRI.
Methods: We conducted a prospective pilot study on adult
patients with confirmed diagnosis of complex hyperplasia with
atypia or endometrioid endometrial cancer during August 2017–
July 2018. Further inclusion criteria required that patients must be
English-speaking, be undergoing hysterectomy with one of two
gynecologic oncologists, be eligible for MRI scan, be comfortable
undergoing MRI scan with or without oral sedation, have less than
severely compromised kidney function, and be able to undergo
MRI at one medical center 7 days prior to hysterectomy. Image
quality, as well as TD and MI image confidence, were measured
on a scale of 1 to 3 (poor, moderate, excellent) by 3 radiologists.
Basic descriptive statistics were performed.
Results: A total of 12 patients (mean age 58.8 years; mean
body mass index: 35.6 kg/m2) were enrolled and underwent
preoperative MRI. Patient population was predominately white
(91.7%). On average, patients received their MRI within 33.3
days of diagnosis and surgery within 38.7 days. Using the
pathology results for TD as the gold standard for comparison, at
least 1 radiologist was able to predict largest TD within 5 mm for
41.7% of patients. All radiologists were not able to predict largest
TD for any single patient. Similarly, using the pathology results
for MI, at least 1 radiologist was able to predict MI within 5%
for 50% of patients. All radiologists were not able to predict MI
for any single patient. Radiologists identified mean MRI image
quality of 2.3. Overall, radiologists were relatively confident
in TD and MI measurements, expressing 2.6 and 2.3 level of
confidence, respectively.
Conclusion: Given the variation between radiologic evaluation,
it is difficult to recommend preoperative MRI as a basis for
measuring TD and MI.
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Department of Family Medicine, Aurora UW Medical Group;
Center for Urban Population Health; Aurora Research
Institute
Background: Legionella pneumophila is an aerobic, pathogenic,
gram-negative bacterium that infects hosts through contaminated
cooling towers and other sources of water. Human infection
presents as potentially life-threatening pneumonia, otherwise
known as Legionnaires’ disease.
Purpose: Our study aimed to identify unrecognized outbreaks
and geodemographic associations of Legionella in eastern
Wisconsin.
Methods: We retrospectively reviewed relevant geodemographic
information of patients who underwent Legionella urine antigen
testing (LUAT) at a single eastern Wisconsin health system from
January 2013 to December 2017. A random sample inclusive of
all positive tests was reviewed. If a patient was ever identified as
positive, only the encounter in which they had their first positive
test was included in the analyses. For all other patients, only
their first negative test was included. Negative cases were used
to investigate significant geodemographic differences in patients
testing positive versus negative. Data was further explored using
chi-squared, 2-sample t-tests and stepwise regression, followed by
binary logistic regression for multivariable analysis. Geographic
information for positive cases was mapped to locate hotspots.
Results: Of all LUAT performed (n=21,599), 0.68% were positive.
Among those in the random sample (n=11,652), positive LUAT
cases were more prevalent in warmer months (June–November
having 86.2% of all positive cases), younger, on average (59.4
years vs 67.7 years for negative cases), and disproportionately
male (70.3% vs 29.7% negative); P<0.0001 for all. The
prevalence of positive cases was higher among nonwhite race/
ethnicity (1.91% vs 1.01%; P<0.0001). Nonwhite race/ethnicity
did not remain significant on multivariable analysis, suggesting
age ± location may be an underlying predictor for infection.
Overall, there were 13 zip codes in the city of Milwaukee
containing 3 or more positive cases of Legionella. Within these
zip codes, there were 58 positive cases. Of these, 36.2% were
in zip codes of low socioeconomic status, 56.9% in zip codes
of middle socioeconomic status, and the remaining 6.9% in zip
codes of high socioeconomic status.
Conclusion: The prevalence of a positive LUAT in eastern
Wisconsin was less than 1%. Patients who are relatively younger,
male, and nonwhite, and who are tested in warmer months, were
more likely to test positive. This methodology, if done in real
time, may complement public health detection of Legionnaires’
disease outbreaks. Further study on built environments near
clustered cases may reveal additional sources of infection.
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Harmonizing Data From Multiple Institutions With a
Common Data Model: An Oncologic Use Case for Risk
Stratification
Joseph M. Plasek, John A. Weissert, Kourosh Ravvaz
Aurora Research Institute
Background: The development and validation of clinical
risk models increasingly relies on heterogeneous data from
multiple institutions to increase the power and rigor of analysis.
Harmonization across different sources requires adoption of the
controlled vocabularies and standardized structure inherent in
some common data models to achieve semantic interoperability.
Both non-muscle invasive bladder cancer (NMIBC) therapy and
research depend on accurate risk stratification, as NMIBC is a
complex, diverse disease. Heterogeneous data, such as data from
patients with NMIBC (eg, clinical, socioeconomic, genetic), is
often collected from different sources that were generated for
various purposes. The standardized structure of a common data
model promotes the harmonization of multi-institutional data sets,
which is necessary to validate existing risk models (eg, European
Organization for Research and Treatment of Cancer [EORTC]
NMIBC recurrence and progression models) and develop new
high-performing NMIBC risk models. Bladder cancer is the ninth
most common cancer, and NMIBC accounts for about 70% of
new bladder cancer cases.
Purpose: To establish feasibility of a common data model for
harmonizing multi-institutional NMIBC data and validating
EORTC models.
Methods: In a retrospective cohort containing 509 and 1331
NMIBC patients from the University of Wisconsin-Madison and
Aurora Health Care, respectively, we utilized the Observational
Medical Outcomes Partnership (OMOP) common data model to
transform the heterogeneous data sets into a standardized format
in order to enforce consistent structure and semantics. EORTC
risk factors for NMIBC include: number of tumors, tumor size,
prior recurrence rate, tumor stage, carcinoma in situ, and grade.
The EORTC risk scores were implemented using the patientlevel prediction tool from the OMOP community. Performance
of EORTC risk scores was assessed using area under the receiver
operator characteristic curve (AUC).
Results: The OMOP common data model was successfully
implemented for NMIBC. Of 1840 patients, 861 (47%) had a
recurrence and 107 (6%) progressed. AUC was 59.63% (95% CI:
56.93–62.33) for recurrence and 74.96% (95% CI: 69.35–80.57)
for progression, consistent with prior studies.
Conclusion: The OMOP common data model provided a scalable
infrastructure for harmonizing multi-institutional data that is
useful for clinical risk stratification. There is demonstrable net
benefit from implementing the OMOP common data model that
supports advanced big data analytic techniques like machine
learning to address existing clinical challenges.
Zika Virus Selectively Kills Glioblastoma Progenitor
Cancer Cells Through AXL Receptor
Parvez Akhtar, Sam D. Zwernik, Amin B. Kassam, Richard
A. Rovin
Aurora Research Institute; Aurora Neuroscience Innovation
Institute
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Background: An oncolytic virus must display tropism for the target
cancer. This oncotropism is mediated by cell surface receptors that
are differentially expressed by the cancer cell. Recent research
into the mechanism of Zika virus (ZIKV)-induced microcephaly
demonstrated that ZIKV has neurotropism for fetal neural progenitor
cells, mediated by AXL, a member of the TAM (Tyro3, AXL, Mer)
family of tyrosine kinase receptors. AXL is frequently overexpressed
in majority of glioblastoma (GBM). We are attempting to repurpose
ZIKV as an oncolytic virus that can specifically target and destroy
glioblastoma through the AXL receptor.
Purpose: We hypothesized that ZIKV could preferentially target and
kill glioblastoma progenitor cancer cells through the AXL receptor.
Methods: ZIKV strain MR766 was propagated in Vero cells.
Viral stock was titrated by plaque assays. Western blot was used
to characterize AXL expression in 5 commercial glioblastoma cell
lines and 10 patient-derived glioblastoma progenitor cell lines. Cell
lines were infected with ZIKV and the percentage of infected cells
quantified by flow cytometry using the pan-flavivirus anti-E protein
Ab 4G2. Cells were treated with AXL inhibitor (R428) and/or human
AXL antibody, then ablated for AXL using CRISPR knockout prior
to ZIKV exposure. Infected cells were quantified by flow cytometry.
Immunofluorescence microscopy was performed to visualize ZIKV
entry and replication. Glioblastoma progenitor cells were terminally
differentiated into different types of brain cells and tested for ZIKV
infection.
Results: In this study, we found that AXL expression varies among
our in-house patient-derived glioblastoma lines (7754, 7730,7714,
7753, 7978, 7759, 8034, 8035, 8049, and 7865) and commercial
(ATCC) glioblastoma lines (LN229, A172, U251, and U87). Flow
cytometry results confirmed that productive ZIKV infection only
occurs in AXL-positive cells. We further found that ZIKV infection
of our patient-derived glioblastoma cell lines was inhibited by AXL
kinase inhibitor R428 in a dose-dependent manner. Furthermore, we
found that blocking AXL receptor using AXL antibody significantly
reduced ZIKV infection in glioblastoma in vitro. AXL knockout
patient-derived glioblastoma lines (7759, 8034, 8035, 8049)
completely blocked ZIKV infection and significantly inhibited viral
replication. Our results highlight the dual role of AXL during ZIKV
infection of glioblastoma: promoting viral entry and facilitating
productive replication. We also found that ZIKV is unable to
replicate in terminally differentiated glioblastoma progenitor cancer
cells, suggesting selectivity for stem cells.
Conclusion: These results clearly suggest that ZIKV displays
oncotropism for glioblastoma progenitor cancer cells, mediated
primarily through AXL receptor.
Weighting Risk Factors for Justice Involvement in
Patients Served by a Large Health System
Sarah E. Reimer, Noah C. Pearce, Christopher R. Beal,
Andrew R. Marek, Maharaj Singh
Center for Urban Population Health; Aurora Research
Institute
Background: Mass incarceration in the United States has caused
incarceration to be an expected life stage in some communities.
Wisconsin incarcerates black males at nearly twice the national
average, and Milwaukee has the most heavily incarcerated zip
code in the country. This study compares justice-involved and nonjustice-involved Milwaukee County residents served by a large
health care system.
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Purpose: This study aims to characterize justice-involved and
non-justice-involved populations.
Methods: Electronic health records from Aurora Health Care
were used to identify a cohort of 564,988 patients, age 18–100
years by end of 2017, that lived in Milwaukee County for 360 or
more days and had 2 or more in-person encounters between 2008
and 2017. Incarceration records were obtained from correctional
facilities administered by Milwaukee County and the state of
Wisconsin between May 2008 and June 2018. Unique persons
were identified within these incarceration records (n=166,563)
and cross-referenced to Aurora’s electronic health record to
determine which people had ever been patients (n=109,723). The
cohort was separated into two groups: justice-involved (n=55,118)
and not justice-involved (n=509,870), based on the presence of
incarceration records for each cohort member. Next, clinical data
from the electronic health record was incorporated into the cohort,
and the two groups were compared using descriptive statistics.
Results: In all, 43.5% were male, 66% white, and 24% African
American, with the remaining belonging to Hispanic and other
races. Mean age of the total population was 48.6 years (SD: 19.5).
Odds ratios (OR) identified major independent predictors of
justice involvement to be male gender (OR:4.1 [4.0–4.2]), African
American race (OR: 3.7 [3.5–3.8]), Medicaid insurance status
(OR: 3.3 [3.2–3.4]), Medicare insurance status (OR: 1.1 [1.1–1.2]),
tobacco use (OR: 2.5 [2.4–2.5]), and drug use (OR: 2.0 [2.0–2.1]).
Patients who had a primary health care provider (OR: 0.7 [0.7–
0.7]), were between 50 and 70 years old (OR: 0.5 [0.5–0.5]), or
were older than age 70 (OR: 0.1 [0.1–0.1]) were less likely to have
been recently justice-involved. Each odds ratio noted herein had a
P-value of <0.01.
Conclusion: Several demographic features associated with
justice involvement in a health system population were identified.
Future work aims to reduce potential confounders, such as patient
neighborhood, and to delineate the impact of justice involvement on
health metrics related to diseases known to be of higher prevalence
in the justice-involved population.
Cardiac Catheterization and Risk Factors of Mortality
Reji Babygirija, Maharaj Singh, Richard A. Rovin, Kessarin
Panichpisal
Aurora Research Institute; Aurora Neuroscience Innovation
Institute
Background: Cardiac catheterization is the gold standard to
diagnose and treat cardiovascular conditions, including pulmonary
hypertension. Estimated annual rates for cardiac catheterization,
for both sexes, range from 171 to 650 per 100,000 population
(>20 years old). The risks and complications following cardiac
catheterization are related to the patient’s concomitant conditions
as well as medications. There are limited data about the factors
that influence the risk of serious adverse events after cardiac
catheterization.
Purpose: Identify the risk factors of mortality for patients
undergoing cardiac catheterization procedure.
Methods: This is a single-center retrospective data collection
study on patients who underwent cardiac catheterization between
January 2008 and March 2017. Demographics, comorbidities, and
medications were included in Cox proportional hazards model.
Results: A total of 11,062 patients were included in the study.
Of these, 66% were male, 89.9% were white, 8.1% were black,
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and mean age of this cohort was 66.3 ± 12.2. Overall mortality
rate was 19.4%. Main predictors of mortality were: age (in 10year increments) at the time of cardiac catheterization procedure
(hazard ratio [HR]: 1.71 [1.62–1.79]; P<0.001); Hispanic
ethnicity (HR: 0.65 [0.52–0.81]; P=0.002); diabetes mellitus
(HR: 1.74 [1.59–1.91]; P<0.001); prior myocardial infraction
(HR: 1.27 [1.16–1.40]; P<0.001); prior coronary artery disease
(HR: 1.61 [1.27–2.05]; P=0.001); hypertension (HR: 1.23 [1.06–
1.42]; P=0.005); smoking (HR: 1.35 [1.20–1.53]; P<0.001);
history of stroke (HR: 1.53 [1.38–1.70]; P<0.001); aspirin (HR:
0.39 [0.33–0.45]; P<0.001); antiplatelet (HR: 0.30 [0.25–0.36];
P<0.001); angiotensin-converting enzyme (ACE) inhibitors (HR:
0.80 [0.73–0.89]; P<0.001); angiotensin II receptor blockers
(ARB) (HR: 0.66 [0.58–0.76]; P<0.001); statin (HR: 0.65 [0.57–
0.74]; P<0.001); nonstatin medication (HR: 0.86 [0.78–0.96];
P=0.0088); and beta blocker (HR: 0.81 [0.72–0.90]; P=0.0002).
Conclusion: This study revealed that the mean survival for cardiac
catheterization patients was more than 6 years. Risk factors for
mortality after cardiac catheterization were age, ethnicity, diabetes,
myocardial infraction, coronary artery disease, hypertension,
smoking, and prior history of stroke. However, medications,
including aspirin, antiplatelets, ACE inhibitors, ARB, statin, nonstatins, and beta blockers, were found to be protective.
Evaluation of Beta Blockers and Renin-Angiotensin
Inhibitors for the Reduction of Anthracycline-Induced
Cardiotoxicity
Evan Mueller, Sarah Zukkoor Zorn, Rachel Pedersen, Vinay
Thohan
Department of Pharmacy, Aurora Health Care; Tendick
Center for Advanced Heart Failure Therapies
Background: Anthracyclines are known to cause dose-related
cardiotoxicity. Clinical trials suggest that beta blockers and
renin-angiotensin inhibitors may attenuate anthracycline-induced
cardiotoxicity. However, studies are small with confounding
factors, and guidelines remain inconsistent regarding optimal use
of these medications for cardioprotection in oncology.
Purpose: To evaluate the role of beta blockers and reninangiotensin inhibitors in reducing anthracycline-induced
cardiotoxicity.
Methods: A retrospective review was conducted for patients,
age 18 years or older, who received anthracyclines at Aurora
Health Care from January 2012 to December 2017. Patients
on beta blockers or renin-angiotensin inhibitors prior to
chemotherapy were compared to those not on these medications.
The primary outcome was incidence of reduced left ventricular
ejection fraction (LVEF), defined as time to first LVEF less than
53% by echocardiogram. Exclusion criteria included baseline
LVEF of less than 53% and no baseline or postanthracycline
echocardiogram. Continuous variables are expressed as means
and standard deviations and compared between groups via
Student’s t-test. Categorical variables are shown as frequency
and compared between groups via chi-squared test. Competing
risks analysis was used to estimate rates of reduced LVEF, and
proportional subdistribution hazards regression was used to
identify a final multivariable model.
Results: A total of 799 patients were included for analysis.
Patients on beta blockers or renin-angiotensin inhibitors at
anthracycline start were older, had higher body mass index,
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lower cumulative life dose, and lower alcohol use. Additionally,
they had higher rates of atrial fibrillation/flutter, coronary
artery disease, diabetes, heart failure, hyperlipidemia, and
hypertension. A final multivariable model identified age of ≥65
years (hazard ratio [HR]: 2.11, 95% CI: 1.27–3.50; P<0.01),
increasing cumulative life dose (HR per 50-unit increase: 1.13,
95% CI: 1.02–1.24; P<0.02), male sex (HR: 2.36, 95% CI: 1.42–
3.93; P<0.01), and prechemotherapy LVEF of <60% (HR: 3.48,
95% CI: 2.13–5.69; P<0.01) as independent predictors of nonnormal LVEF.
Conclusion: Within this cohort, patients on beta blockers or
renin-angiotensin inhibitors at start of anthracycline therapy did
not have a significant difference in incidence of postchemotherapy
LVEF of <53% compared to patients not on those medications.
Of note, the patients on medications had a higher incidence
of preexisting cardiac disease, which may mask the potential
cardioprotective benefits, confounding the results.

POSTER PRESENTATIONS

Real-Life Impact of Physician Awareness of a Positive
Stool DNA Test on Subsequent Colonoscopy Outcome
in Colorectal Cancer Screening
Julien Fahed, Aboud Affi
Department of Gastroenterology, Aurora Health Care
Background: A recent study of 244 subjects looked into clinical
outcome of colonoscopy based on the physician’s awareness of
the positive stool DNA test result. The study compared unblinded
unmonitored colonoscopy with blinded monitored colonoscopy.
Purpose: We present a larger real-life study on the impact of
physician awareness of a positive stool DNA test on colonoscopy
results.
Methods: Chart review of 1413 patients who had a positive
stool DNA followed by documented subsequent colonoscopy
was done. Attention was paid to the indication of the procedure
in the colonoscopy report. A total of 5 patients were excluded;
3 of these had unknown indication and 2 a finding of “other
carcinoma.” Findings were recorded and patients were divided
into two groups. Group 1 included patients who had indication
of “stool DNA testing” or its equivalent, while group 2 included
all the other indications. Only the index lesion was recorded.
Advanced adenoma was defined as an adenoma larger than 10
mm or that had high-risk features such as villous transformation
or high-grade dysplasia. Nonadvanced adenoma was defined
as an adenoma smaller than 10 mm with no high-risk features.
Statistical analysis with chi-squared was done to compare the
proportions. A P-value less than 0.05 was considered statistically
significant.
Results: Of the 1408 patients, 979 (70%) had an indication of
“stool DNA testing” or its equivalent, while 429 (30%) had another
indication (to which we assumed the provider was not aware of
the positive stool DNA testing). Results of group 1 and group 2
were as follows: Adenocarcinoma was found in 1.8% vs 1.4%,
respectively (P=0.56); advanced adenoma was found in 24.8%
vs 21.2%, respectively (P=0.14); >10-mm adenoma was found
in 7.25% vs 6.99%, respectively (P=0.86); and nonadvanced
adenoma was found in 28.7% vs 31.2%, respectively (P=0.57).
Finally, no adenomas were found in 37.4% vs 39.2%, respectively
(P=0.33).

278 JPCRR • Volume 6, Issue 4 • Fall 2019

Conclusion: Following a positive stool DNA test, 1 out of 3
colonoscopies are done without the physician’s awareness of
the positive result. Fortunately, there was no difference in the
outcome of colonoscopy whether the physician was aware of the
positive result or not.
Calling Urgent and Emergent Cesarean Sections: Are
We on Time?
Naomi Light, Jessica J. F. Kram, Kayla Heslin, Cheryl Bauer,
Mariah Peterson, Carla Kelly
Departments of Obstetrics and Gynecology, Women’s
Health Services, and Labor and Delivery, Aurora Sinai
Medical Center; Aurora UW Medical Group; Center for Urban
Population Health; Aurora Research Institute
Background: In October 2016, our health care facility adopted
a new classification system for cesarean sections in an effort to
have on-time cesarean deliveries among typically unscheduled
patients with time-sensitive cesarean sections. Patients with timesensitive cesarean sections include those with an immediate threat
to life (emergent) or those with maternal or fetal compromise
that is not immediately life threatening (urgent). Even when
a cesarean delivery is deemed emergent or urgent (ie, timesensitive), patient-, staff-, anesthesia-, and procedure-related
delays may occur.
Purpose: Our quality improvement study aimed to assess
whether caregiver education would improve on-time cesarean
deliveries.
Methods: We retrospectively studied all emergent (<15 minutes)
and urgent (<30 minutes) cesarean sections within one labor and
delivery unit. Patients 6 months prior to caregiver education were
compared with those following nursing and provider education.
Nursing and provider education (September 2017–October
2017) focused on development of communication pathways and
reorientation to decision-making timelines. To compare groups,
descriptive statistics and multivariable linear regression were
used to predict time to incision.
Results: A total of 149 patients pre-caregiver education and
185 patients post-caregiver education were included. Patients
in the two groups did not differ by age, race/ethnicity, or
body mass index (BMI). On univariate analysis, mean time
from decision to incision, as well as mean time from decision
to anesthesia in patients who did not already have anesthesia
initiated, significantly improved (P<0.01). Additionally, delays
significantly improved (67.1% vs 53.5%; P=0.01), although
documented reasons for delays did not (P=0.14). Overall, only
21.1% of delayed patients (n=199) were emergent cesarean
sections. Multivariable regression suggested case classification,
patient delay, BMI, and time to anesthesia, but not the educational
intervention, significantly predicted time to incision (P≤0.01;
R2=0.86).
Conclusion: Although an improvement in decision-toincision time was observed, it was unrelated to the educational
intervention performed. Even so, concurrent nursing education
initiatives aimed at improving cesarean section timing may have
contributed to on-time emergent and urgent cesarean deliveries.
Ultimately, ongoing education and team collaboration should
continue in order to further improve cesarean delivery timing and
patient care.
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Criteria for Conversion From a Basal-Bolus Insulin
Regimen in Patients With Type 2 Diabetes to a Regimen
of a Glucagon-Like Peptide-1 Receptor Agonist With
Basal Insulin
Christopher Klink, Kelsey Gardetto, Thomas Dilworth
Department of Pharmacy, Aurora Health Care
Background: Diabetes mellitus is a metabolic disease in which
the body’s production and response to insulin is altered. Type 2
diabetes mellitus is a subset of the disease in which the pancreas
continues to produce insulin; however, the level of endogenous
insulin production decreases over time. Many patients with type
2 diabetes mellitus eventually require basal-bolus insulin as part
of their medication regimen; however, this regimen is complex
and increases the risk of hypoglycemia and weight gain. A newer
regimen for type 2 diabetes mellitus includes the combination of
a glucagon-like peptide-1 receptor agonist (GLP-1RA) plus basal
insulin. This regimen is less complex, safer, promotes weight loss,
and has the potential to reduce cardiovascular risk. This regimen
is incorporated in the American Diabetes Association guidelines
as part of the step therapy for diabetes. What is less well known
is which patients, if any, may be successfully de-escalated from
basal-bolus insulin to this regimen.
Purpose: To identify patient characteristics that predict a successful
conversion from a basal-bolus insulin regimen to a basal insulin plus
GLP-1RA regimen.
Methods: A retrospective case series was performed on 32 patients
with type 2 diabetes mellitus. Of the 32, 24 patients successfully
made the conversion from a basal-bolus insulin regimen to GLP1RA plus basal insulin; 8 patients were unsuccessful. Unsuccessful
conversions were defined as discontinuation of the GLP-1RA due
to intolerance, expense, or clinical decline seen in lab test values.
Patient characteristics, including weight, hemoglobin A1c, and
blood glucose (average and range), were tracked. C-peptide level,
years since diagnosis, and insulin requirements also were analyzed
to identify if there may be a correlation with patients who could
successfully be converted.
Results: Patients who successfully converted to a GLP-1RA plus
basal insulin regimen had an average weight loss of 5.5 ± 2.0 kg and
a reduction in average blood sugar of 16.3 ± 51.2 mg/dL at 3 months.
They also had an average reduction in A1c of 0.83%; in comparison,
patients who were unsuccessful had an average increase in A1c of
0.625%. The average C-peptide value for successfully converted
patients was 2.77 ng/ml compared to 0.97 ng/ml for patients who
failed the new regimen due to clinical decline.
Conclusion: Patients with type 2 diabetes mellitus presently
managed on basal-bolus insulin can be successfully converted to a
GLP-1RA plus basal insulin if appropriately screened and selected.
Vagal Response During Pulmonary Vein Isolation With
Cryoballoon Ablation
Janet C. Tsang, Lynn Erickson, Imran Niazi, Jasbir S. Sra,
M. Eyman Mortada
Aurora Cardiovascular Services; Aurora Research Institute
Background: Vagal nerve response, seen during cryoballoon
ablation of the pulmonary veins, can be attributed to the ablation’s
effect on the ganglionated plexi. This effect is demonstrated with
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drops in blood pressure and heart rate during pulmonary vein
isolation with cryoballoon ablation.
Purpose: To evaluate surrogate markers for vagal response during
pulmonary vein isolation with cryoballoon ablation.
Methods: A total of 22 patients with paroxysmal atrial fibrillation
underwent pulmonary vein isolation with a 28-mm second-generation
cryoballoon using a 3-minute freeze technique. Two or more lesions
were performed for each vein. Initial blood pressure, nadir blood
pressure, time to reach -30 degrees, time to reach -40 degrees, time
from start of thaw to reach zero degrees (TT0), time from start of
thaw to the nadir blood pressure (TTNBP), total freeze time, minimal
temperature reached, and time from start of freeze to vein isolation
by electrogram were recorded. Clustered data for each vein were
analyzed using the common slope and linear intercept mixed model.
Results: All patients (mean age: 62.5 ± 8.4 years; male sex: 69%,
body mass index: 31.7 ± 5.7; mean CHA2DS2-VASc score: 1.8 ±
1.2; white race: 100%; hypertension: 56%; coronary artery disease:
38%; sleep apnea: 50%; mean left atrial volume index: 58.6 ±
17.8 ml/m2; left ventricular ejection fraction of ≥55: 100%) had
paroxysmal atrial fibrillation. Univariate analysis demonstrated
that the best surrogate marker for vagal response was the TT0 in the
inferior veins. The drop in blood pressure increased up to fourfold,
with a onefold increase in thawing duration (TT0 in left inferior
vein: 3.040, P<0.020; TT0 in right inferior vein: 4.261, P<0.046).
Average TT0 and drop of systolic blood pressure were 7.5 seconds
and 21 mmHg, respectively, in the left inferior vein, and 7 seconds
and 20.8 mmHg, respectively, in the right inferior vein. The second
marker was the TTNBP, seen only in the right superior vein, with
average time of 86.6 seconds, causing an average of systolic blood
pressure drop of 24.6 mmHg. A threefold increase in TTNBP
caused onefold increase in blood pressure drop (0.323, P<0.037).
Conclusion: Vagal response during cryoballoon ablation was seen
mainly during isolation of the inferior pulmonary veins.
Evaluation of Opioid Prescribing Habits and Morphine
Milligram Equivalent Trends at Aurora Health Care
Brent Davis, Prati Wojtal, Joel Pietryga, Barry McClain,
Tristan F. Edwards
Department of Pharmacy, Aurora Health Care
Background: Aurora Health Care’s opioid stewardship committee
(OSC) was created to optimize and standardize pain management
in patients while minimizing the use of opioids and reducing the
number of patients who develop opioid use disorder. In 2016, the
Centers for Disease Control and Prevention (CDC) established
guidelines for prescribing opioids, but execution and awareness of
the current guidelines is inconsistent across the system. An initiative
of the OSC is to ensure that all providers are following the CDC
opioid-prescribing guidelines. The specific goals of this committee
are to: 1) reduce the total amount of opioids prescribed in morphine
milligram equivalents (MMEs); 2) reduce the number of patients
co-prescribed opioids and benzodiazepines; and 3) minimize the
number of patients started on chronic opioid agonist therapy.
Purpose: An opioid-prescribing dashboard was designed to assess
baseline opioid-prescribing practices and the goals of the OSC. The
opioid-prescribing dashboard provides leadership visibility to MME
prescribing trends and prescribing practices deviating outside the
CDC opioid-prescribing guidelines.
Methods: OSC members identified important definitions and metrics
for reporting in the dashboard. Metrics were adopted from literature
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reviews of successful opioid dashboards at other health systems
and in harmony with CDC opioid-prescribing guidelines. MME
reports are the key catalyst to the dashboard’s analysis. In 2018,
Aurora linked daily MME calculations to opioid prescriptions in
its electronic health record (EHR). In October 2018, CDC MME
conversion factors were used to validate EHR’s daily MME
calculations for opioids prescribed. Incorrect or missing MME
calculations were identified and addressed. An initial report was
developed allowing for baseline reporting during November 1, 2018–
January 31, 2019. The data was filtered by provider, specialty, and
service area and then manipulated for reporting on the dashboard.
Results: During the 3-month period, 105,874 opioid prescriptions,
with an average daily MME of 40, were prescribed. The average
monthly MME total was 21.8 million, with 29% and 15% of
patients tallying a daily MME of ≥50 and ≥90 on opioids. Aurora
averaged 1229 new chronic opioid patients each month and currently
accounts for 8307 total chronic opioid patients. In January 2019,
68% of patients prescribed opioids were prescribed benzodiazepines
between September 1, 2018, and January 31, 2019.
Conclusion: The dashboard identifies trends and areas for
improvement in prescribing opioids with the intention to encourage
safe and appropriate prescribing for Aurora patients.
Strengthening the Culture of Well-Being in Graduate
Medical Education
Jacob Bidwell, Tricia La Fratta, Deborah Simpson, Nicole Eull
Departments of Family Medicine, Graduate Medical
Education, and Academic Affairs, Aurora Health Care
Background: Physician burnout is a safety, quality, and workforce
issue. As a result, well-being is an Accreditation Council
on Graduate Medical Education’s (ACGME) accreditation
requirement for the sponsoring institution and individual programs.
Aurora Health Care’s graduate medical education (GME) leaders
convened a retreat of key stakeholders (program directors, resident
council leaders, system leaders) to develop a well-being strategic
plan. Each program completed the ACGME’s Inventory of
Elements of Your Program’s Well-Being plan, and GME leaders
completed Inventory of Elements of Your Institution’s Well-Being
plan. At the retreat cross-cutting findings were identified, with
action items identified.
Purpose: To improve our resident/fellow well-being scores
through the development of clear GME protocols, procedures, and
initiatives with pre/post metrics.
Methods: Major GME strategic action items focused on aligning
physician contracts with teaching roles, procuring funds for a
medical education well-being position, developing direct access for
trainees to behavioral health, developing a systemwide budget for
ensuring a standard for adequate time and space for pursuing wellbeing, and developing a crisis communication protocol. The impact
of our interventions was measured by the evidence-based Mayo
Well-Being Index (MWBI) and the ACGME’s well-being survey.
Results: All action items have been implemented, including
appointment of a 0.80 FTE well-being director. Our resident/fellow
wellness scores were positive. MWBI results showed a 4.6% decrease
(17.3% to 12.7%) of residents/fellows (n=158) reporting high levels
of distress over the last 11 months, well below the national average
of 34.9% (>1700 residents/fellows). Our ACGME well-being survey
results were within normal range per national metrics.
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Conclusion: All GME action items were completed, with the
percentage of at-risk scores decreasing by 4.6% over an 11-month
period. Going forward, GME will continue to monitor MWBI
and ACGME scores and support residency/program-specific
interventions as part of a continuous improvement.
Understanding the Top Health Issues Facing Milwaukee
County
David Frazer, Carrie Stehman, Maddie Johnson, Kayla
Heslin, Elizabeth A. Duthie, Marianne Klumph
Center for Urban Population Health; University of Wisconsin
School of Medicine and Public Health; Aurora Research
Institute; Aurora UW Medical Group; University of WisconsinMilwaukee
Background: Health is determined by complex interactions
among socioeconomic factors, health behavior, health care, and
physical environment. Since 2012, the Milwaukee Health Care
Partnership’s triennial Community Health Needs Assessment
(CHNA) has reported the top health issues identified by residents
and community leaders in Milwaukee County. The CHNA serves
as the foundation from which hospitals, community health centers,
and local health departments develop their community health
improvement strategies.
Purpose: To better understand the health of Milwaukee County
and what influences it.
Methods: The CHNA is informed by three key sources:
Community Health Survey (a 14-minute, phone-based survey of
Milwaukee County residents that addresses adult/child health risks,
health behaviors, and community health needs); key informant
interviews (conducted with health experts and community leaders
to identify community health needs, contributing social factors,
and organizations best suited to address those issues); and Health
Compass Milwaukee (a compilation of publicly available data,
including sources mentioned above, on a recently launched
website). We utilized all three sources to create the CHNA to help
understand the burdens, disparities, inequities, and determinants
that contribute to health issues.
Results: The top 5 issues of greatest concern were chronic disease,
mental health, substance use, violence, and access to health care.
Among chronic disease conditions, heart disease was identified as
the leading cause of death in Milwaukee County, with a premature
death rate of 1228 per 100,000 lives, which is higher than the
rest of Wisconsin. Among mental health outcomes, suicide rates
in Wisconsin jumped 55.6% from 2000 to 2017 but remained
relatively level in Milwaukee County. Regarding substance use in
Milwaukee County, the opioid-related overdose death counts are
concerning, with an increase from 144 in 2012 to 337 in 2017. In
terms of violence against individuals that inflicts physical harm,
Milwaukee County (945.1 violent crimes per 100,000 individuals)
has a higher rate of violence than the rest of Wisconsin (282.9).
On a positive note, regarding health care access, the Affordable
Care Act spurred Milwaukee County’s uninsured rate to drop from
12.6% in 2013 to 7.2% in 2017.
Conclusion: Health is complex. It is our hope that this assessment
and website will help amplify providers and community
conversations about the importance of cross-sector collaboration
for health improvement.
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Impact of Obstetrics and Gynecology Resident Workload
and Protected Time Interventions on Well Being
Morgan S. Altinok, Naomi Light, Deborah Simpson, Carla Kelly
Department of Obstetrics and Gynecology, Aurora Sinai
Medical Center; Department of Family Medicine and Academic
Affairs, Aurora Health Care; Aurora UW Medical Group
Background: Between 22% and 60% of practicing physicians
are reported to have experienced burnout, with OB/GYN resident
burnout having been reported at 90%. Duty-hour limitations were
implemented for patient safety and have been associated with some
increase in overall resident quality of life and potential sacrifices in
resident education and patient care. Contributors to burnout (and
drivers of engagement) include workload and job demands, lack
of control and flexibility over personal schedule and workload,
poor work-life integration, and numerous check box requirements
(filling out surveys, module requirements, duplicates, paperwork).
Purpose: To improve well-being and decrease burnout among OB/
GYN residents by implementing workload changes and protected
time for wellness.
Methods: Effective July 2017, we changed 3 resident workload
protocols. 1) For weekend rounding, residents continue to round on
all antepartum and gynecology patients at the end of each 24-hour
shift, but faculty became responsible for completing all postpartum
rounding. 2) Weekday postpartum rounding was redistributed, and
the number of patients decreased from >10 to maximum of 6–7
patients per junior resident. 3) No resident service obligations on
Sundays with 2 months with no residents on night float. Quarterly
wellness mornings began in September 2017, using protected
education time for residents. We measured pre/post changes in
well-being through a brief well-being check in card (WBCIC) and
Mayo Well-Being Index (MWBI).
Results: Resident response rates ranged from 10 to 12. WBCIC
baseline (September 2017), midintervention (May 2018), and
postintervention (December 2018) scores on item “Time spent
on wellbeing” improved from 1.6 to 2.1 to 2.3 (scale: 1=pitiful to
4=excellent). The item “The work I do is meaningful to me” began
at 4.9, then remained constant at 5.2 (scale: 1=strongly disagree to
7=strongly agree). The MWBI identifies those at risk of adverse
outcomes due to poor quality of life, burnout, and suicidal ideation
if their score is >5. MWBI scores remained more than 1.2 points
below the 5.0 cutoff, ranging from 1.2 to 1.8 during report period
with seasonal variation (residents were less well in winter). Wellness
mornings were most frequently used for sleep, connecting with family/
friends/other residents, exercise, and personal health appointment.
Conclusion: The workload interventions were associated with a
positive trend in overall well-being and finding meaning in work,
making progress towards our goal of creating a workplace dynamic
where burnout is combated and well-being is promoted.
Opportunity for Protected Administrative Time Improved
Resident Well-Being and Patients’ Experience of Care
Vy T. Dinh, Thomas J. Harrington, Joseph Vogelgesang,
Abdulrehman Siddiqui, Catherine de Grandville, Will
Lehmann, Deborah Simpson
Department of Family Medicine, Aurora Health Care; Aurora
UW Medical Group; Department of Academic Affairs, Aurora
Health Care
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Background: Well-being is a critical issue for health care, with
burnout rates measured at up to 63% among family physicians. A
recent meta-analysis of burnout and patient experience studies found
a strong association between resident and physician wellness and
quality of patient care. Nationally, indirect patient care responsibilities
(visit notes, inboxes, phone calls) has been identified as a significant
contributing factor for burnout. Primary care physicians who spend,
on average, 6 hours/week on electronic health record work outside
normal clinical time are 3 times more likely to report burnout. Our
family medicine residents identified lack of time to manage patientrelated “in-boxes” as a barrier to their well-being.
Purpose: To determine if allocating one-half day/week to complete
indirect patient care tasks reduced residents’ perceived administrative
tasks burden and improved the patient’s experience.
Methods: Once clinical schedules were established, residency
program leaders (faculty, clinic, chief residents) allowed residents
on noncall rotation blocks to notify their preceptor if they wanted
to take a half-day to perform administrative tasks. Ongoing and
repeated communication using multiple forums and formats was
provided to clarify the purpose and process for using this allocated
time. The effectiveness of this intervention was evaluated using two
outcomes (CG-CAHPS, Mayo Well-Being Index) and two process
surveys (end-of-rotation, resident wellness) as pre/post metrics.
Results: On process survey results, the percentage of residents
reporting that “things are piling up so high I don’t feel I can
overcome them” decreased by 16% from >1 times/week to 1–2/
month. Further analysis revealed that as the number of half-days
taken increased (from 4.0 to 4.5 half-days/rotation), residents
felt more under control (1.4 to 1.7, with 1=strongly agree to
5=strongly disagree). Outcome measures demonstrated a positive
pre/post change: Mayo Well-Being Index scores showed 1.2
positive change (on 6-point scale); CG-CAHPS percentiles in our
two family medicine residency clinics increased (between-visit
communication by 4 and 5 points, respectively, and test-results
communication by 5 and 7 points, respectively).
Conclusion: Our results demonstrate that protected time for
administrative tasks improves residents’ sense of control and wellbeing. Patient quality care scores also improved, highlighting
the strong association between physician wellness and patient’s
experience of care.
Running and Rapping Our Way to Wellness: Internal
Medicine Residency Approach to Preventing Burnout
Siri Neelati, Prakash Nallani, Kathy Scigacz, Richard Battiola,
Tanya Shah, Xiaoxiao Qian, Deborah Simpson
Department of Internal Medicine, Aurora Sinai Medical
Center; Aurora UW Medical Group; Department of Family
Medicine and Academic Affairs, Aurora Health Care
Background: Physician burnout has led to increased cardiovascular
disease, shorter life expectancy, problematic alcohol use, depression,
and suicide. A recent meta-analysis on burnout and patient experience
highlighted the strong association between physician wellness and the
quality of patient care. Unfortunately, burnout in internal medicine
ranks among the highest of all specialties, with rates up to 76%.
Purpose: To facilitate resident mental and physical well-being
through initiatives focused on supportive colleague relationships
and exercise.
Methods: We implemented two related interventions. 1) RAPS
(Resident Advisor for Peer Success) is a structured peer advisor
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program for incoming interns to jump-start a “connection” with
their continuity clinic team shortly after match day. This early and
sustained contact provides interns with an immediate resource for
questions/support and ongoing connections with senior residents
and a faculty advisor. 2) Fit4Life intervention continued to build/
support colleague relationships through personal fitness. Wellness
challenges between trainee years were held to promote physical
health per American Heart Association (AHA) exercise guidelines.
Three measures — a Fit4Life survey, semi-structured interviews
with interns, and Mayo Well-Being Index (MWBI) — were used to
evaluate process and outcomes.
Results: Fit4Life pre-, during, and postchallenge data showed that
less than 20% of internal medicine residents met AHA guidelines:
150 minutes/week of aerobic physical activity. Challenge period
results showed a modest but not significant increase in exercise.
Average completion rate was 83% of internal medicine residents.
Exercise, per AHA recommendations, was paired >50% of time
with another activity (eg, watch/listen to television, movies, music,
podcasts; connecting with family/friends). RAP intern interviews
(13 of 13 [100%]) revealed that 85% were supportive of RAPS
and 100% met weekly with RAPS team member(s) at continuity
clinic. MWBI scores throughout intervention were well below
instruments established at risk level for burnout (5.0), with below
burnout scores ranging from 3.1 preintervention (February 2018)
to 2.3 postintervention (December 2018).
Conclusion: The results of our well-being interventions focused
on supportive colleague relationships through RAPS and exercise
reveal high participation rates and support but no significant impact
on physical or mental health as measured by Fit4Life and MWBI.
Health Care Utilization as a Proxy to Introduce a Novel
Disease Screen in Pediatric Populations
Angela A. Navarrete-Opazo, Maharaj Singh, Mindy R. Waite,
Sheldon R. Garrison
Aurora Research Institute
Background: The global economic burden of treating genetically
distinct conditions is growing rapidly. An interest in prophylactic
treatment and pharmacogenetic decision-making has emerged in
concert with an increasing usage of genetic tools, such as prenatal
genetic testing, biomarker assays, and personal genomic tests, to
presymptomatically identify these conditions. However, little is
known about the optimal timing of these approaches to best impact
patient care and, where applicable, to consider the cost of care in
providing prophylactic treatment.
Purpose: To determine the optimal developmental timepoint
in early childhood to screen for certain health conditions
presymptomatically and measure the financial impact of the
resulting clinical actions.
Methods: A retrospective review of vaccination compliance,
as a proxy for health care utilization, of the 3,969,953 eligible
individuals from 2012 through 2018 using de-identified data from
the Wisconsin Immunization Registry. Further analysis across
racial groups was assessed, and the financial impact of changes
in cost of care. Concurrently, a parental survey was conducted
to determine preference for the timing and disease inclusions of
genetic tests.
Results: Overall vaccination rates revealed maximal compliance
during the first 6 months of visits, with the highest compliance rate
at month 4 (71.2%). However, this rate significantly differed when
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racial groups were assessed independently, with compliance in
Caucasian children highest at 4 months (80.0%) and all other racial
backgrounds highest at 2 months (66.3%–72.6%).
Conclusion: Results demonstrated that health care utilization is
greatest within the first 4 months after birth, suggesting an optimal
time to administer tests designed to detect health conditions
presymptomatically.
Incidence of Atypia or Malignancy on Surgical Excisional
Biopsy From Benign Papillomas Diagnosed on Core
Biopsy
Salik Nazeer, Mark T. Lawton, Joseph J. Weber, Franklin R.
Zuehl
Departments of Radiology, Surgery, and Pathology, Aurora
Health Care
Background: Solitary intraductal papillomas are benign,
proliferative, mass-forming lesions arising in the lactiferous
ductal system of the breast. Solitary intraductal papillomas are
encountered with core biopsy of the breast, with an incidence of
approximately 5%. Although papillomas are considered benign,
the lesions frequently are surgically excised after diagnosis on
core biopsy. Excision has historically been performed due to
a certain percentage of core biopsy cases being reclassified
(upstaged) to atypia or malignancy based on pathologic results
of excisional biopsy.
Purpose: The objective of this study is to determine the incidence
of solitary intraductal papillomas that were subsequently
reclassified to atypia or malignancy following complete surgical
excision.
Methods: A retrospective analysis was performed that included
review of pathology results and other data for intraductal papillomas
diagnosed by core biopsy from 2010 through 2016 at participating
Milwaukee-metropolitan Aurora Health Care facilities. Female
patients with documented personal history of breast carcinoma
prior to the core biopsy procedure and patients under the age of
18 were excluded from the study. Reports were reviewed by 4
different investigators to identify subsequent excisional biopsy
results as well as follow-up radiology to confirm diagnoses. All
data were reported using descriptive statistics.
Results: Our initial review included 390 patients who had the
diagnosis of papilloma from a core biopsy. Of those, 154 patients did
not undergo excisional biopsy (39%). Of the 236 patients who had
excisional biopsies, 203 patients had benign specimens (86%), 15
had atypia with intraductal papilloma (6%), 11 had adjacent atypia
(5%), and 7 had malignancy (3%). The 7 patients with malignancy
were reevaluated radiographically to assess for concordance of
the core biopsy and excisional biopsy results. Of the 7, 3 patients
with core biopsy-proven papilloma demonstrated malignancy
within the existing lesion (1%) on subsequent excisional biopsy,
and 4 patients were excluded due to lack of concordance between
radiology and pathology findings comparing core biopsy location
to excisional biopsy position.
Conclusion: In our facilities, only 1% of patients with initially
diagnosed benign breast papillomas at core biopsy demonstrated
true associated malignancy on the excisional biopsy specimen, a
significantly lower rate than reported incidences in most similar
previous studies. Our study is limited by our sample size. Further
prospective studies would be helpful to further validate this data.
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Specialty Access for the Uninsured Program: System
Costs Before and After Enrollment
Sally Smaida, Widalys Calderon Torres, Jessica J. F. Kram,
Steve Ohly, Dennis J. Baumgardner
Aurora Walker’s Point Community Clinic; Department of
Family Medicine, Aurora UW Medical Group; Center for
Urban Population Health
Background: The Specialty Access for Uninsured Program
(SAUP) is a partnership within Milwaukee County in which
safety-net primary care clinics are paired with hospital/health
systems for specialty care. Health systems are assigned a portion
of the income-eligible uninsured patients in the county, who then
receive specialty services at no cost.
Purpose: To examine differences in cost, hospitalization, and
use of emergency department (ED) and urgent care prior to and
following SAUP enrollment.
Methods: We prospectively identified and retrospectively
reviewed patients, age ≥18 years, residing in Milwaukee County
who were enrolled in SAUP during 2017. Several variables were
retrospectively collected prior to and following initial SAUP
enrollment. Calendar-year cost data were identified per patient
for the year prior to SAUP enrollment (2016), the year of SAUP
enrollment (2017), and the year following SAUP enrollment (2018).
Costs in 2016 and 2018 were adjusted to match 2017 costs. Paired
t-tests were used to compare care (eg, number of hospital admits 12
months prior to and following SAUP enrollment) and cost-related
differences. A P-value less than 0.05 was considered significant.
Results: Of the original 99 patients enrolled in SAUP, 13 were
excluded for not following up with care. Previously reported patient
characteristics remained similar. Only 67.4% of SAUP patients
were established patients 12 months prior to SAUP enrollment;
73.3% were established patients 6 months prior to enrollment. Mean
time between enrollment and specialty service visit was 30.8 days
(median: 25.0 days), and 46.5% had contact with a primary care
provider following specialty services. Mean number of hospital
admissions (0.14 vs 0.15), ED admissions (0.36 vs 0.30), and urgent
care visits (0.02 vs 0.00) 12 months prior to and following SAUP
enrollment, respectively, were not statistically different. However,
the mean number of no-show visits 12 months prior to and following
SAUP enrollment declined significantly (0.89 vs 0.34, respectively;
P=0.001). Mean charges significantly increased from 2016 to
2017 ($7048 vs $35,091, respectively; P=0.002) and from 2016 to
2018 ($7048 vs $14,552, respectively; P=0.034), but significantly
decreased from 2017 to 2018 ($35,091 vs $14,552, respectively;
P=0.013).
Conclusion: Charge increases during the years of specialty episode
care are reflective of care delivered. A significant decline in the
number of no-show visits indicates the possible development of
a clinic relationship, often seen when patients establish trust in a
medical home.
Cryptococcal Antigen Testing in an Integrated Medical
System: Eastern Wisconsin
Marianne Klumph, Brian Hoeynck, Dennis J. Baumgardner
Department of Family Medicine, Aurora UW Medical Group;
Center for Urban Population Health; Aurora Research
Institute
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Background: Cryptococcosis is an environmentally acquired
endemic fungal infection causing serious disease in usually
immunocompromised hosts. Environmental associations of
pathogenic species include certain trees, soils, bird guano, and
parks. Little is known about the frequency and distribution of
cryptococcosis in Wisconsin. Cryptococcal antigen detection
(CrAg) test is more than 90% sensitive and specific and is
frequently used to screen patients with likely disease.
Purpose: We aimed to explore the geodemographic and clinical
features of Wisconsin patients tested with CrAg.
Methods: We conducted a retrospective review of all patients at
Aurora Health Care having CrAg testing from January 2013 to
April 2017. Patients with 1 or more positive CrAg test(s) were
always considered positive, and basic demographic and clinical
features were used from the first identified positive test. For
patients always testing negative, clinicodemographic features were
taken from the first test. Basic descriptive statistics were computed
and chi-squared or t-tests were used as appropriate. Binary logistic
regression was used for multivariable analysis.
Results: A total of 1465 CrAg tests (741 on serum, 723 on
cerebrospinal fluid, 1 other) were performed on 1211 unique
patients (mean age: 53.7 ± 16.5; female sex: 50.2%; white race:
73.9%) during this time. At least 1 CrAg test was positive in 23
of 1211 patients (1.9%); 21 of 23 (6 transplant patients, 5 HIV, 4
malignancy, 6 other) were immunocompromised (vs 13 predicted;
P<0.001). Positive patients were disproportionately male (19 of 23
[3.2% of all those tested] vs 4 female [0.7% of all those tested];
P=0.002) and nonwhite (12 of 23 [3.8% of all those tested] vs 11
white [1.2% of all those tested]; P=0.012). These associations, but
not age, were significant independent predictors in multivariable
models. Overall, 17 separate zip codes had 1 positive case, 2 city
of Milwaukee zip codes had 3 each, with the closest two patients
living 193 meters apart; no other case clustering or close proximity
to waterways was observed (41% were less than 162 m from green
space, similar to historical controls). Positive patients were more
prevalent in Milwaukee (2.9% of those tested vs 1.6% of all those
tested in rest of state), but this was not significant (P=0.21).
Conclusion: Among all CrAg-tested patients, male gender,
nonwhite race/ethnicity, and immunocompromised status, not
natural environmental features, predicted positive tests. To our
knowledge, this is the first report regarding the distribution of
cryptococcosis in Wisconsin.
Hot Spotting Medically Complex At-Risk Patients:
Does It Decrease Hospital and Emergency Department
Admissions?
Melissa Grube, Glenda Sundberg, Dane Olsen, Jessica J.F.
Kram
Department of Family Medicine, Aurora Health Care; Aurora
St. Luke’s Family Practice Center; Aurora UW Medical
Group; Center for Urban Population Health
Background: Our previous research has shown that hot spotting
medically complex at-risk patients may improve patient outcomes
and decrease health care costs.
Purpose: The purpose of this project was to extend our previous
efforts for the most complex patients at the Family Practice
Center clinic in Aurora St. Luke’s Medical Center and add one
additional site, the Family Care Center clinic at Aurora Sinai
Medical Center.
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Methods: During 2018, new at-risk patients were identified
and tracked at two family medicine sites. Each patient verbally
consented to voluntary participation in the hot spotting
intervention. A new interdisciplinary team was created at the
second clinic site, which required additional buy-in to the
intervention’s concepts. We compared number of hospital
admissions, emergency department (ED) visits, and estimated
cost savings before and after a 9-month intervention period.
Basic descriptive statistics were conducted to describe the overall
population. Paired t-tests were used as appropriate. A P-value less
than 0.05 was associated with statistical significance.
Results: A total of 35 new “hot spot” patients were identified.
This patient cohort had mean age of 56 years and was
predominately female (69%). Prevalence of mental illness was
89%. Additionally, 66% had communication problems (17%
with primary language other than English), 63% had caregivers
suffering from caregiver fatigue, and 49% had safety concerns.
Furthermore, 34% of patients were considered underutilizers
of health care. Although not statistically significant, mean total
ED visits (3.6 vs 2.7; P=0.102) and hospital admissions (1.3
vs 0.8; P=0.087) decreased per person. Charlson scores did
not change following the intervention. Cost reduction based
on these decreased rates was determined at $87,000 ($2485/
patient), equating to a 2.09 return on investment. Even without
knowing the financial aspects, clinic staff were very satisfied with
the intervention. Overall, 97% of provider respondents felt hot
spotting patients was a good idea after the intervention, compared
to 78% before, and 76% felt the intervention helped them take
better care of their patients.
Conclusion: Extending our hot spotting intervention to an
additional clinic site showed similar decreases in hospital and ED
utilization as previously reported. Moreover, there continued to
be cost savings at both sites. Therefore, our pilot efforts will be
extended to a third nonresidency clinic site in 2019 for further
evaluation.
Reduced Esophageal Cooling With Left Atrial Roof and
Posterior Wall Cryoablation
Dhruv Chawla, Lynn Erickson, Mohamed Djelmami-Hani,
Imran Niazi
Aurora Cardiovascular Services; Aurora Research Institute
Background: Thermal esophageal injury is a rare but devastating
complication of pulmonary vein isolation using radiofrequency
energy or cryoablation (CRYO) and also radiofrequency ablation
of posterior wall (PW). Risk of esophageal injury with PW and
roof CRYO is unknown. Since PW and roof CRYO has recently
been advocated, we studied minimum esophageal temperature
(MET) to assess safety of PW and roof CRYO.
Purpose: To assess safety of PW and roof CRYO for atrial
fibrillation.
Methods: CRYO was performed in 16 patients (mean age: 64
± 9 years; mean left atrial volume: 59 ± 24 mL/m2; male sex:
12) with atrial fibrillation (8 paroxysmal, 8 persistent). Following
pulmonary vein isolation, CRYO balloon was dragged across
the roof and PW with lesions delivered at half-balloon-width
intervals. CRYO balloon and esophagus were precisely localized
to 1 mm accuracy with Navik 3D mapping system (APN Health,
LLC, Waukesha, WI). Lesions were maintained for 3 minutes
unless a MET of <28°C was encountered. Incidence of lesions
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with a MET of 28°C was compared between pulmonary veins,
PW, and roof sites using Fisher’s exact test.
Results: Lesions were distributed as follows: roof (n=81), PW
(n=34), and pulmonary veins (right superior [RSPV, n=19], right
inferior [RIPV, n=21], left superior [LSPV, n=19], and left inferior
[LIPV, n=17]). Occurrence of MET of <28°C was: 1 of 81 roof,
2 of 34 PW, 2 of 21 RIPV, 2 of 17 LIPV, and no RSPV/LSPV
lesions. MET of <28°C was more common in RIPV (9.5%) and
LIPV (11.8%) when compared to roof (1.2%) and PW (5.9%);
these differences were statistically significant (P<0.001 for all
comparisons).
Conclusion: Significant esophageal cooling with CRYO is less
common at the roof and PW than in inferior pulmonary veins, and
the overall incidence is low. CRYO of PW and roof may be safer
than CRYO of pulmonary veins.
Goals of Care Conversations: An Evaluation
Elizabeth A. Duthie, Colleen M. Galambos, Theresa
Frederick, Jacob Verkuilen, Tim Jessick
Center for Urban Population Health; Helen Bader School
of Social Welfare, University of Wisconsin-Milwaukee;
Continuing Professional Development, Aurora Health Care;
Palliative Medicine, Aurora Health Care
Background: Growing evidence suggests that physician and
patient discussions about goals of care improve quality of life,
quality of dying, and decrease end-of-life intensity of care.
However, these conversations do not occur at the frequency
desired by seriously ill and dying patients. Practitioners
recommend new approaches to increase the frequency and
quality of such conversations. The “Teaching Primary Palliative
Care” training offered through Aurora Health Care’s continuing
professional development office is one new approach aimed to
equip physicians with skills to increase the frequency and quality
of goals of care conversations.
Purpose: To evaluate the Teaching Primary Palliative Care
(TPPC) training to determine if physicians report increased
comfort in engaging in goals of care conversations with seriously
ill and dying patients posttraining.
Methods: TPPC training occurs in three stages. Stage A: Initial
self-assessment completed online. Participants complete a survey
in which they answer a series of questions designed to measure
comfort level in engaging in goals of care communications with
their seriously ill and dying patients. Stage B: Attend an in-person
training session on communication skills and techniques on
having goals of care conversations with patients. Stage C: Second
self-assessment completed online within about 3 months after
physicians practiced and applied skills in their clinical practice.
In fall 2018, 78 Aurora physicians completed stages A and B of
the training, resulting in 37 completed stage A and stage C selfassessments. To assess for increased comfort level, the stage A
and stage C assessments were statistically analyzed using the
1-sided sign test.
Results: Compared to their reported comfort level prior to
completing TPPC training, physicians’ comfort level after training
increased in 4 out of 5 circumstances related to engaging in
goals of care conversations with patients: discussing CPR/do not
resuscitate (P=0.018); discussing hospice or palliative care referral
(P<0.001); discussing artificial hydration or nutrition (P=0.001);
and discussing prognosis specifics (P=0.002).
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Conclusion: Findings suggest that TPPC training increases
the comfort level of physicians to engage in goals of care
conversations with seriously ill and dying patients. Next steps
for this project include a longitudinal study to determine whether
physicians continue to be more comfortable in these circumstances
6–9 months after completing the training.

Evaluation of the Association Between Thrombotic
and Bleeding Outcomes and Bridging Anticoagulation
Strategies in Patients With Left Ventricular Assist
Device

Effectiveness of SBIRT Training Program for AdvancedStanding Master of Social Work Students

Department of Pharmacy, Aurora Health Care; Tendick
Center for Advanced Heart Failure Therapies

Elizabeth Miecielica, Lisa Berger

Background: In patients with a left ventricular assist devices
(LVAD), long-term anticoagulation with a warfarin regimen
is required to prevent thromboembolic events, including
device thrombosis. Patients with LVAD frequently experience
subtherapeutic international normalized ratio (INR) and/or
interruption of anticoagulation. In these cases, bridge therapy
should be considered, taking into account the balance between
thrombotic and bleeding risk. Bridging strategies include
anticoagulation with intravenous heparin and low-molecularweight heparin.
Purpose: To assist in the expansion of anticoagulation approaches
for the LVAD population.
Methods: This is a retrospective, observational, single-center
study of patients with LVAD. Patients were identified through
the Interagency Registry for Mechanically Assisted Circulatory
Support (INTERMACS) database. Patients implanted from
January 2012 to December 2017 and who survived 30 days
posthospitalization were followed until time of explant,
transplant, or death. A bridging event is defined as the start of
anticoagulation until 30 days post. Primary outcomes include
thrombotic events and major bleeding events as reported in the
INTERMACS registry. A generalized estimating equations model
was used to analyze associations between baseline and temporal
predictors of thrombotic and major bleeding events.
Results: A total of 156 patients were included. During followup time, 109 major bleeding events occurred, with 30 unique
bridging events utilizing enoxaparin and 227 utilizing heparin.
We adjusted for baseline predictors associated with major
bleeding events. Therapeutic INR per protocol was associated
with reduced risk of bleeding (relative risk [RR]: 0.47 [0.26–
0.87]; P=0.02). Compared to no bridging, patients bridged on
heparin experienced significantly fewer bleeding events (RR:
0.43 [0.21–0.87]; P=0.02). There was no difference between
patients bridged on enoxaparin compared to no bridging (RR:
0.91 [0.34–2.34]; P=0.85). Results on thrombotic events are
pending.
Conclusion: Compared to patients who were not bridged,
patients bridged with enoxaparin had no increase in bleeding
events, whereas patients bridged with heparin experienced
lower rates of bleeding. Although known bleeding risk factors
were adjusted for, these results may be limited by physician
discretion of bridging based on individual patient risk. Further
data analysis will be conducted to identify independent bleeding
and thrombotic risk factors to assist in anticoagulation practices
in patients with LVAD.

Helen Bader School of Social Welfare, University of
Wisconsin-Milwaukee; Center for Urban Population Health
Background: Screening, Brief Intervention, and Referral to
Treatment (SBIRT) for substance misuse is an evidence-based,
public health approach for early identification and intervention of
risky alcohol and other substance use. Recent SBIRT dissemination
efforts have included training grants to medical schools and
university programs of nursing and social work. These efforts
come at a time of greater focus by higher education accreditation
bodies on competency-based education.
Purpose: The purpose of this study was to examine the
effectiveness of a SBIRT training program for advanced-standing
Master of Social Work students. The objective was to develop a
program that would train students to competency in delivering an
evidence-based SBIRT protocol.
Methods: A total of 91 students participated voluntarily in the
study. All students received the same SBIRT training, consisting
of an initial motivational interviewing module (8 hours) followed
by the SBIRT protocol module (4 hours) conducted within a course
on substance misuse interventions. Competency was assessed by
a modified version of a valid brief intervention adherence scale
as used by two trained raters. Raters independently listened to
an audiotaped SBIRT protocol assignment submitted by each
participant. Students achieved competency if at least 80% of the
SBIRT protocol elements were deemed executed by both raters.
Fidelity to each of the 4 SBIRT protocol subsections of engaging,
focusing, eliciting, and planning also was examined.
Results: The overall average interrater reliability as assessed
by proportion of agreement was 0.82, or moderate agreement
(0.90=high agreement). In total, 75 of the 91 students (82%)
achieved competency, while fidelity to each of the SBIRT protocol
subsections was as follows: engaging 96%; focusing 92%; eliciting
46%; and planning 56%. For students who did not achieve
competency (n=16, or 18%), most did not deliver to fidelity the
eliciting (94%) and planning (88%) subsections.
Conclusion: The SBIRT training program was effective in
training to competency 4 out of 5 Master of Social Work students.
The vast majority of students, regardless of overall competency,
delivered the engaging and focusing subsections with fidelity.
Regardless of overall competency, most students tended to miss
elements in the planning subsection, while students who did not
achieve competency tended to also miss elements in the eliciting
subsection, indicating more time and/or revised training strategies
are needed to increase fidelity and, thus, competency.
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Epidemiology of Male Breast Cancer
Santhi D. Konduri, Maharaj Singh, George C. Bobustuc,
Richard A. Rovin, Amin B. Kassam
Aurora Research Institute; Neuro-Oncology Research,
Aurora Health Care; Aurora Neuroscience Innovation
Institute
Background: Male breast cancer is relatively rare (less than
1% of all cases of breast cancer) and usually treated similarly to
female breast cancer. There are a very limited number of studies for
characterization of male breast cancer, and most studies are small
and underpowered. We report the results of a retrospective study
using national cancer database from years 2004 to 2014.
Purpose: The purpose of this study was to determine the survival
and risk factors for male breast cancer in using a large study
population in the United States.
Methods: In this retrospective study we included 19,795 patients
with a follow-up period of up to 11 years. In this population, the
majority of patients were non-Hispanic white (74.8%), 12.1% were
black, 0.5% were Hispanic, and the remaining were other races.
Results: The rate of incidence was 7.2% in 2004 and increased
to 10.3% in 2014. The significant predictors of mortality included
cancer stage II, III, and IV vs stage 0 (hazard ratio [HR]: 1.5, 2.7,
and 9.9, respectively), age (HR: 1.04), surgery (HR: 0.4), radiation
(HR: 0.8), chemotherapy (HR: 0.8), hormonal (HR: 0.8), tumor
size for every 10-mm increase (HR: 1.01), and estrogen receptor
(ER)-positive and progesterone receptor (PR)-positive (HR: 0.8).
Socioeconomic factors such as income, insurance, and facility type
also contributed to the higher risk for mortality. Higher CharlsonDayo index resulted in higher mortality rate. Kaplan-Meier
survival probability was higher in patients who underwent surgery
(P<0.001), received radiation (P<0.001), received chemotherapy
(P<0.001), or received hormonal therapy (P=0.0126). The patients
identified with ER and PR positivity (P<0.0001) also had higher
survival probability. In a subset of patients (n=7880), HER2/neu
was available from 2010 to 2014). Survival probability was higher
in patients with negative HER2/neu expression (P<0.001), whereas
mortality risk was 1.7 times higher among patients diagnosed with
positive HER2/neu expression.
Conclusion: This study with a large patient population showed
that socioeconomic factors, cancer stage, tumor characteristics
(size and grade), and higher Charlson-Dayo scores contributed
to higher mortality among male patients diagnosed with breast
cancer. Among treatment modalities, surgery was most effective
followed by radiation, chemo-, and hormonal therapy. Patients
identified with positive ER and PR had better survival probability.
Biomarker identification followed by timely diagnosis of the
treatment, irrespective of socioeconomic status, is likely to reduce
the risk for mortality. A subset analysis showed that positive
HER2/neu expression had higher mortality.
Cardiac Catheterization and Acute Ischemic Stroke:
Who Is at Risk?
Maharaj Singh, Reji Babygirija, Richard A. Rovin, Kessarin
Panichpisal
Aurora Research Institute; Aurora Neuroscience Innovation
Institute
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Background: Cardiac catherization is a well-established invasive
procedure that is used to diagnose and treat coronary artery disease.
Estimated annual rates for cardiac catherization range from 171
to 650 per 100,000 population (>20 years of age) for both sexes.
Cardiac catherization has been associated with an increased risk
of acute ischemic stroke. Timely and specialized treatment of
ischemic stroke is crucial for increasing survival and reducing
morbidity.
Purpose: Identify predictors of acute ischemic stroke in patients
undergoing cardiac catherization procedure.
Methods: Data on patients who underwent cardiac catherization
from January 2008 to March 2017 was retrospectively collected
and analyzed. Demographics and comorbidities were compared
among those patients with and without incident stroke using area
under the curve c-statistic.
Results: A total of 35,268 patients were included in the study.
Of these, 59% were male, 87.5% were white, 10.7% were black,
and mean age was 66.1 ± 12.7 years. Acute ischemic stroke was
reported among only 0.4% of these patients. The main predictors
for acute ischemic stroke, based on a c-statistic of 0.68, were age
(in 10-year increment) at the time of procedure (adjusted odds ratio
[aOR]: 1.37, 95% CI: 1.10–1.63; P<0.001), atrial fibrillation (aOR:
2.36, 95% CI: 1.16–4.80; P=0.0182), hypertension (aOR: 0.53,
95% CI: 0.34–0.82; P=0.0046), and history of stroke (aOR: 3.15,
95% CI: 1.94–5.11; P<0.001).
Conclusion: Retrospective assessment of nearly 10 years of
cardiac catherization procedures in a single center revealed that
incident acute ischemic stroke is a relatively rare occurrence. The
independent predictors for stroke were age, atrial fibrillation, and
history of prior stroke. Importantly, hypertension was found to be
protective of acute ischemic stroke; however, data on evidencebased therapy (such as beta blocker, statin, or antiplatelet use) were
not analyzed due to missing values for more than two-thirds of
the patients. In the future we will strive to develop a risk score
for predicting acute ischemic stroke among the patient population
undergoing cardiac catherization.
Evaluation of Sox2 Expression in Glioblastoma Stem
Cells During Zika Virus Infection
Beau Adams, Sam D. Zwernik, Amin B. Kassam, Richard A.
Rovin, Parvez Akhtar
Aurora Research Institute; Aurora Neuroscience Innovation
Institute
Background: Glioblastoma is a deadly form of brain cancer.
Standard treatment involves surgery followed by chemotherapy
and radiation. Most tumors recur within 6 months, fueled by a
small population of glioblastoma stem cells (GSCs) that resist and
survive treatment. There are no pharmacological agents currently
available for specific targeting of GSCs. Zika virus (ZIKV) is a
flavivirus and is linked to congenital microcephaly in addition to
other neurological manifestations. It appears that ZIKV selectively
targets normal neural stem cells in the developing brain, causing
the microcephaly. The specificity is due to receptor-mediated cell
entry: a tyrosine kinase receptor, AXL, present on neural stem
cells, specifically binds ZIKV and permits cell entry. We examined
the effect of ZIKV on Sox2, a transcription factor that controls the
self-renewal of stem cells.
Purpose: The purpose of this study is to understand the role of
Sox2 in ZIKV infection in glioblastoma cancer stem cells.
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Methods: ZIKV strain MR766 was propagated in Vero cells.
Viral stock was titrated by plaque assays. Glioblastoma patientderived cell lines were infected with ZIKV, and the percentage
of infected cells was quantified by flow cytometry using a
pan-flavivirus antibody. Western blot was used to characterize
Sox2 expression in 5 glioblastoma patient-derived cell lines.
Immunofluorescence microscopy was used to visualize Sox2
levels after ZIKV infection.
Results: We found that Sox2 expression varies among the
glioblastoma patient-derived cell lines (7754, 7730, 7714, 7753,
and 7978) and is inversely correlated with AXL expression. We
further found that ZIKV infection inhibits Sox2 levels in a dosedependent manner in all 5 glioblastoma cell lines.
Conclusion: Our results suggest that ZIKV infection causes loss
of self-renewal through Sox2 in glioblastoma cancer stem cells.
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